Avance Clinical will attend the CKD Summit 2026, March 16–18 in Boston, a leading global forum focused on accelerating innovation in chronic kidney disease.
At the event, we will meet with biotech companies to discuss upcoming clinical development plans and share how our Renal & Cardiometabolic Center of Excellence supports the efficient design and delivery of mid‑ to late‑phase CKD programs through scientifically grounded, feasibility‑driven trial strategies.
Biotechs joining the Summit can gain insight into how Avance Clinical’s Renal & Cardiometabolic Center of Excellence designs practical, patient‑focused CKD studies that reflect real‑world patient needs.
Our access to high‑burden patient regions and global nephrology investigator networks enables more efficient and predictable study delivery through:
An integral function of our Renal & Cardiometabolic Center of Excellence is to engage early and continuously with key opinion leaders (KOLs) in nephrology. Their scientific insight strengthens protocol design, supports operational feasibility, and ensures alignment throughout the entire study lifecycle.
Dr. Graham Birrell, Renal & Cardiometabolic Therapeutic Area Head, and Dr. Manthinda (Manthi) Hettiarachchi, Senior Director and Head of Renal & Cardiometabolic Operational Strategy, will be on‑site to discuss your development priorities and explore solutions aligned to your clinical and operational goals.
Renal & Cardiometabolic Therapeutic Area Head
Renal & Cardiometabolic Operational Strategy Head
We welcome the opportunity to meet with you at the CKD Summit. Graham and Manthi will be available to discuss your development goals and share how our team supports efficient, feasibility‑driven CKD study execution.
Avance Clinical is a full-service Contract Research Organization (CRO) with clinical operations in Australia, New Zealand, Asia, North America, and Europe.
Level 22, 91 King William Street
Adelaide, SA
Australia 5000
Phone: +61 8 8249 4788
For all media enquiries: media@avancecro.com
